Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H9N3O3 |
Molecular Weight | 171.154 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC=C(N1CCO)[N+]([O-])=O
InChI
InChIKey=VAOCPAMSLUNLGC-UHFFFAOYSA-N
InChI=1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3
Molecular Formula | C6H9N3O3 |
Molecular Weight | 171.154 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:11:19 UTC 2023
by
admin
on
Fri Dec 15 15:11:19 UTC 2023
|
Record UNII |
140QMO216E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ESSENTIAL MEDICINES LIST |
6.5.1
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-VATC |
QA02BD02
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
NDF-RT |
N0000175435
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.2
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
P01AB01
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-VATC |
QG01AF01
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
J01XD01
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
A02BD01
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
J01RA10
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
G01AF01
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
A02BD03
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
D06BX01
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
A02BD11
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
J01RA04
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
LIVERTOX |
NBK548609
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
CFR |
21 CFR 530.41
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
17486
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-VATC |
QP51AA01
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-VATC |
QA02BD03
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
NCI_THESAURUS |
C279
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/11/875
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
267008
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
EPA PESTICIDE CODE |
120401
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
P01AB51
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
A02BD02
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
339111
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
J01RA03
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
A02BD08
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-VATC |
QD06BX01
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
247907
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
21687
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-VATC |
QJ01XD01
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
514715
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
NDF-RT |
N0000007663
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-VATC |
QA01AB17
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
61891
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-VATC |
QA02BD08
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
NDF-RT |
N0000007663
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-VATC |
QA02BD01
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
||
|
WHO-ATC |
A01AB17
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000090285
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
207-136-1
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
4173
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
1032
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
443-48-1
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
C651
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
DTXSID2020892
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
69587
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
Metronidazole
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
1442009
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
6909
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
D008795
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
METRONIDAZOLE
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | Description: A white or pale yellow, crystalline powder; odourless or almost odourless.Solubility: Sparingly soluble in water; slightly soluble in ethanol (~750 g/l) TS and ether R.Category: Antitrichomonal; antiamoebic. Storage: Metronidazole should be kept in a well-closed container, protected from light. Additional information: Metronidazole is stable in air, but darkens on exposure to light. Definition: Metronidazole contains not less than 99.0% and not more than 101.0% of C6H9N3O3, calculated with reference to the dried substance. | ||
|
50687
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
1790
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
SUB08922MIG
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
CHEMBL137
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
6922
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | RxNorm | ||
|
50364
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
140QMO216E
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
3129
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
140QMO216E
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
m7506
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | Merck Index | ||
|
METRONIDAZOLE
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY | |||
|
DB00916
Created by
admin on Fri Dec 15 15:11:19 UTC 2023 , Edited by admin on Fri Dec 15 15:11:19 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> INHIBITOR |
POTENT
|
||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
POPULATION: CHILDREN AND ADOLESCENTS |
|
||
MIC | BIOLOGICAL |
|
PATHOGEN: ANAEROBES |
|
||
Tmax | PHARMACOKINETIC |
|
FORMULATION: IMMEDIATE RELEASE |
|
||
MIC | BIOLOGICAL |
|
PATHOGEN: ANAEROBES |
|
||
Biological Half-life | PHARMACOKINETIC |
|
POPULATION: ADULTS |
|
||
Biological Half-life | PHARMACOKINETIC |
|
POPULATION: NEONATES 7 DAYS AND OLDER |
|
||
Biological Half-life | PHARMACOKINETIC |
|
CHILD-PUGH CLASSIFICATION: CLASS A |
|
||
MIC | BIOLOGICAL |
|
PATHOGEN: ANAEROBES |
|
||
Biological Half-life | PHARMACOKINETIC |
|
POPULATION: NEONATES GESTATIONAL AGE 36-40 WEEKS |
|
||
Biological Half-life | PHARMACOKINETIC |
|
POPULATION: NEONATES GESTATIONAL AGE 32-35 WEEKS |
|
||
Biological Half-life | PHARMACOKINETIC |
|
CREATININE CLEARANCE: LESS THAN OR EQUAL TO 65 ML/MIN |
|
||
Tmax | PHARMACOKINETIC |
|
FORMULATION: EXTENDED RELEASE |
|
||
Biological Half-life | PHARMACOKINETIC |
|
CHILD-PUGH CLASSIFICATION: CLASS C |
|
||
Biological Half-life | PHARMACOKINETIC |
|
CHILD-PUGH CLASSIFICATION: CLASS B |
|
||
Biological Half-life | PHARMACOKINETIC |
|
POPULATION: NEONATES GESTATIONAL AGE 28-30 WEEKS |
|
||